 Posted: Tue 0:27, 15 Mar 2011 Post subject: WHO notified the major companies to stop artemisin |
|
| WHO notified the major companies to stop malaria, artemisinin as a monotherapy
Cause a patient resistance. WHO in favor of (I) for the combination therapy drugs (ACT),tory burch outlet, this parasitic resistance is unlikely. Combination therapy, for example, and Norvatis's Coartem (artemetherpluslumefantrine,belstaff outlet, artemether plus lumefantrine) fixed-dose combination therapy, the cure rate of 95%. Before the 18 companies identified during the (I) monotherapy, including Sanofi-Aventis, the Indian companies Cipla and Belgium Dafra, most of which are located in the company's base in China and India. But the reaction of each company is different. Cipla company told Scrip, they will continue marketing (I) monotherapy,tory burch reva, because there is no case reports of drug resistance. However, if there is drug resistance, they would reconsider the plan. wHO the new Chairman of the Department of malaria,belstaff milano, Dr. ArataKochi pointed out that particularly concerned about the reduction, this usually means the start of drug resistance. For example, the old anti-malarial combination therapy of a sulfadoxine pyrimethamine (sulfadoxine-pyrimethamine), 1977 was first introduced to Thailand, the cure rate to 1009 / 6, but the last five years has dropped to only 10%. Table of oral artemisinin derivatives monotherapy drug manufacturer pharmaceutical manufacturer of oral artesunate monotherapy CiplaCosmos · 34 · countries India and Kenya Dafra Guilin Pharma of China Belgium GVS Beijing Holley-Cotec Company India pharmaceutical company in China IPCA of India Kinapharma Ghana Mediplantex Vietnam Mepha Switzerland Pharbaco Vietnam Vietnam Sanofi-Aventis/Africasoins France Traphaco oral artemether monotherapy Arenco DafraB Belgium Belgium ETDZS pharmaceutical companies in China GVS IPCA of India Indian pharmaceutical companies in China Kunming single oral dihydroartemisinin Drug treatment of GVS India Beijing Holley-Cotec companies new technology companies in China based on single-drug artemisinin derivatives oral treatment Holley pharmaceutical company pharmaceutical company in China Kunming, China,timberland shoes, Vietnam Mediplantex Source: wHO5 month, WHO said, and Sanofi-Aventis of France Ipca and Cipla in India and other pharmaceutical companies, including 13 of its phase-out of receiving oral artemisinin for malaria treatment recommendations prescribed preparations, high-quality single preparations of artemisinin are also a major manufacturer of this column. These companies will work to adopt artemisinin-based combination therapy (ACT) malaria marketing efforts to meet the WHO's recommendations. So far, three countries have begun to take appropriate regulatory measures. ArataKochi said: |
|
